Seb's question from a previous thread;In the AusBiotech...

Seb's question from a previous thread;

In the AusBiotech Investment Conference back on the 15th June, Geoff mentioned that the company was “entering into a number of contracts”.

My questions are:

- What does he define as “a number” - i.e. at least 3?.

- Are these contracts still on track, i.e. has anything occurred to delay the process significantly.

- Given that contracts can take anything from 6 weeks to 6 months to sign, can we expect a number of signings before Christmas?

- Would all these potential contracts / signings result in royalties immediately (or say within 2 quarters after signing) or are 1 or 2 contracts for tests or devices that may be introduced to the market in the future (i.e. beyond 6 months or a year).